GeneDx Holdings Revenue 2020-2025 | WGS
GeneDx Holdings revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
GeneDx Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $305 |
| 2023 | $203 |
| 2022 | $235 |
| 2021 | $212 |
| 2020 | $179 |
| 2019 | $196 |
|
GeneDx Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $117 |
| 2025-06-30 | $103 |
| 2025-03-31 | $87 |
| 2024-12-31 | $96 |
| 2024-09-30 | $77 |
| 2024-06-30 | $71 |
| 2024-03-31 | $62 |
| 2023-12-31 | $57 |
| 2023-09-30 | $53 |
| 2023-06-30 | $49 |
| 2023-03-31 | $43 |
| 2022-12-31 | $61 |
| 2022-09-30 | $83 |
| 2022-06-30 | $36 |
| 2022-03-31 | $54 |
| 2021-12-31 | $58 |
| 2021-09-30 | $43 |
| 2021-06-30 | $47 |
| 2021-03-31 | $64 |
| 2020-12-31 | |
| 2020-09-30 | $39 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.932B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.894B | 27.52 |
| HCA Healthcare (HCA) | United States | $107.981B | 17.88 |
| CVS Health (CVS) | United States | $99.714B | 11.47 |
| Elevance Health (ELV) | United States | $70.690B | 10.37 |
| Cencora (COR) | United States | $68.633B | 22.14 |
| Natera (NTRA) | United States | $27.439B | 0.00 |
| DiDi Global (DIDIY) | China | $24.144B | 19.73 |
| Labcorp Holdings (LH) | United States | $20.782B | 15.85 |
| Medpace Holdings (MEDP) | United States | $16.867B | 41.88 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| ICON (ICLR) | Ireland | $13.220B | 13.12 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.984B | 0.00 |
| Viatris (VTRS) | United States | $12.411B | 4.46 |
| CochLear (CHEOY) | Australia | $12.126B | 0.00 |
| Solventum (SOLV) | United States | $11.737B | 12.11 |
| Revvity (RVTY) | United States | $10.495B | 19.33 |
| Charles River Laboratories (CRL) | United States | $8.253B | 15.90 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.215B | 0.00 |
| HealthEquity (HQY) | United States | $8.132B | 32.55 |
| Avantor (AVTR) | United States | $7.895B | 12.06 |
| Sonic Healthcare (SKHHY) | Australia | $6.712B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.894B | 35.14 |
| Bausch + Lomb (BLCO) | Canada | $5.571B | 36.58 |
| Sotera Health (SHC) | United States | $4.492B | 21.66 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 22.50 |
| Alignment Healthcare (ALHC) | United States | $3.414B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.815B | 35.42 |
| Concentras Parent (CON) | United States | $2.453B | 15.56 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.099B | 8.10 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.863B | 11.12 |
| Establishment Labs Holdings (ESTA) | $1.753B | 0.00 | |
| Organon (OGN) | United States | $1.659B | 1.81 |
| Progyny (PGNY) | United States | $1.623B | 34.33 |
| Teladoc Health (TDOC) | United States | $1.430B | 0.00 |
| Omada Health (OMDA) | $1.342B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.157B | 18.50 |
| CareDx (CDNA) | United States | $0.850B | 13.89 |
| Embecta (EMBC) | United States | $0.811B | 4.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 9.78 |
| Nutex Health (NUTX) | United States | $0.730B | 11.05 |
| Pomdoctor - (POM) | China | $0.614B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.556B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.541B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.527B | 0.00 |
| CryoPort (CYRX) | United States | $0.427B | 0.00 |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.416B | 18.66 |
| Auna S.A (AUNA) | Luxembourg | $0.402B | 6.03 |
| Charming Medical (MCTA) | $0.383B | 0.00 | |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.377B | 0.00 |
| KindlyMD (NAKA) | United States | $0.355B | 0.00 |
| SBC Medicals (SBC) | United States | $0.330B | 7.23 |
| Agilon Health (AGL) | United States | $0.312B | 0.00 |
| LifeMD (LFMD) | United States | $0.267B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.230B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.116B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.97 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |